The Federal Drug Administration (FDA) is warning consumers about unapproved semaglutide, a popular weight loss drug associated with the brand names







FDA warns consumers about risks of unapproved versions of weight loss drugs [MontZJdGLHB]

FDA warns consumers about risks of unapproved versions of weight loss drugs [MontZJdGLHB]

| 1h 28m 28s | Video has closed captioning.

The Federal Drug Administration (FDA) is warning consumers about unapproved semaglutide, a popular weight loss drug associated with the brand names Ozempic and Wegovy. #keto gummy kelly clarkson #safest weight loss medication #qvc weight loss gummies #apple cider vinegar vs gummies #diet pills without exercise

Aired: December 27, 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Related to This Episode

  • Q&A with Heidi Thomas

    Q&A with Heidi Thomas

    Writer & Executive Producer of FDA warns consumers about risks of unapproved versions of weight loss drugs [MontZJdGLHB] on the secret of the show.

  • Relive the Drama with Gif Recaps

    Relive the Drama with Gif Recaps

    Miss an episode? Catch up on all things Poplar with our gif recaps.

  • Visit the Official Site

    Visit the Official Site

    Dive deeper into FDA warns consumers about risks of unapproved versions of weight loss drugs [MontZJdGLHB] with cast Q&As, expert blogs, BTS photos, and more!

  • Explore the Modern Midwives Blog

    Explore the Modern Midwives Blog

    Experienced midwives discuss how FDA warns consumers about risks of unapproved versions of weight loss drugs [MontZJdGLHB] intersects with modern day Midwifery.

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now